EUVIMEDOpdag EUVIMED
Multizentrische StudieKlinische Studie

12‐Month Clinical Outcomes Using a Variable‐Loop Circular Catheter for PFA in a Chinese Atrial Fibrillation Population

Hailong Tao, Heng Cai, Hua Fu, Shaowen Liu iD, Songwen Chen iD, Lianjun Gao, Xiaomeng Yin iD, Yumei Xue iD, Hongtao Liao, Rui Zeng iD, Kaijun Cui, Jianzeng Dong

Pacing and Clinical Electrophysiology · 2026-11 · 49 (11) · 1851-1861

DOI: 10.1111/pace.70294 ↗

At a glance

Multizentrische Studie in Pacing and Clinical Electrophysiology, published online on 2026-05-28. Written by Hailong Tao and 11 co-authors. Institution: The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Major MEDLINE topics: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. 20 references. Funded by: Johnson & Johnson MedTech.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The variable‐loop circular catheter (VLCC) showed promising outcomes in European and US studies, but evidence is limited in Asian populations. afIRE trial assessed 12‐month safety and effectiveness of the VLCC in Chinese patients with symptomatic, drug‐refractory paroxysmal atrial fibrillation (AF).

Methods

AfIRE was a prospective, multicenter, single‐arm trial for adults undergoing first‐time pulmonary vein isolation (PVI) with the VLCC. Primary effectiveness was 12‐month freedom from atrial arrhythmia recurrence (systematically assessed by electrocardiogram and Holter monitoring at 3‐, 6‐, and 12‐months post‐ablation or when symptomatic), repeat ablation, procedural failure, or Class I/III antiarrhythmic drug use. Safety was defined by incidence of primary adverse events (PAEs).

Results

Of 142 patients enrolled, 123 (mean age 57.0 years, 45.5% female) comprised the main‐stage cohort (patients treated with the VLCC after roll in). Median procedure, pulsed field ablation (PFA), and fluoroscopy times were 115.0, 36.1, and 5.0 min, respectively. Acute PVI was achieved in all patients, with 89.4% without acute reconnection and 11.4% undergoing non‐PV ablation. Twelve‐month primary effectiveness success and freedom from symptomatic recurrence were 74.8% and 87.0%, respectively. Safety was favorable, with PAEs in 2 patients (1.6%; vascular complications; unlikely device‐related). Multivariable analysis of the primary endpoint showed that preserved left ventricular ejection fraction (≥ 60%) was associated with 86% reduction in odds of 12‐month atrial arrhythmia recurrence; diabetes, ≥ 9 symptomatic AF episodes, and < 48 valid PFA applications (16 ablations) numerically increased odds of recurrence.

Conclusion

The first Asian VLCC experience demonstrated favorable 12‐month effectiveness and excellent safety, reinforcing reproducibility across global AF populations. Clinical Trial Registration NCT05552963

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationPulmonary VeinsCatheter AblationHumansFemaleTreatment OutcomeMaleMiddle AgedChinaProspective StudiesEquipment DesignRecurrenceIrreversible Electroporation TherapyEast Asian People

Author keywords

VARIPULSE CatheterVARIPULSE Platformcatheter ablationparoxysmal atrial fibrillationpulmonary vein isolationpulsed field ablationvariable‐loop circular catheter

Authors and institutions

  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Tianjin Medical University General Hospital, Tianjin, China.
  • West China Hospital of Sichuan University, Chengdu, China.
  • Shanghai General Hospital, Shanghai, China.
  • The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Guangdong Provincial People's Hospital, Guangzhou, China.

ORCID profiles: Shaowen Liu, Songwen Chen, Xiaomeng Yin, Yumei Xue, Rui Zeng

Funding

  • Johnson & Johnson MedTech

Cite

APA

Tao, H., Cai, H., Fu, H., Liu, S., Chen, S., Gao, L., Yin, X., Xue, Y., Liao, H., Zeng, R., Cui, K., & Dong, J. (2026). 12‐Month Clinical Outcomes Using a Variable‐Loop Circular Catheter for PFA in a Chinese Atrial Fibrillation Population. Pacing and Clinical Electrophysiology, 49(11), 1851-1861. https://doi.org/10.1111/pace.70294

Vancouver

Tao H, Cai H, Fu H, Liu S, Chen S, Gao L, et al. 12‐Month Clinical Outcomes Using a Variable‐Loop Circular Catheter for PFA in a Chinese Atrial Fibrillation Population. Pacing and Clinical Electrophysiology. 2026;49(11):1851-1861. doi:10.1111/pace.70294

BibTeX
@article{Tao2026,
  author = {Tao, Hailong and Cai, Heng and Fu, Hua and Liu, Shaowen and Chen, Songwen and Gao, Lianjun and Yin, Xiaomeng and Xue, Yumei and Liao, Hongtao and Zeng, Rui and Cui, Kaijun and Dong, Jianzeng},
  title = {12‐Month Clinical Outcomes Using a Variable‐Loop Circular Catheter for PFA in a Chinese Atrial Fibrillation Population},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1851--1861},
  doi = {10.1111/pace.70294}
}
Start for free →